about
Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirusHuman papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspectiveCost analysis of Human Papillomavirus-related cervical diseases and genital warts in SwazilandThe impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.Incidence of anogenital warts in Germany: a population-based cohort study.The economic burden of human papillomavirus-related precancers and cancers in Sweden.Pediatricians are more supportive of the human papillomavirus vaccine than the general public.Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.Large scale genotype comparison of human papillomavirus E2-host interaction networks provides new insights for e2 molecular functions.Economic burden of human papillomavirus-related diseases in Italy.Human papillomavirus seropositivity and subsequent risk of HIV acquisition in rural South African womenInfection and cervical neoplasia: facts and fiction.Human papillomavirus genotype distribution in cervical samples collected in routine clinical practice at the Nantes University Hospital, FranceApplying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran.Quantifying the broader economic consequences of quadrivalent human papillomavirus (HPV) vaccination in Germany applying a government perspective framework.Effective strategies for HPV vaccine delivery: the views of pediatriciansPrevalence and seroprevalence of low-risk human papillomavirus in Korean women.The economic burden of noncervical human papillomavirus disease in the United States.Human papillomavirus in infants: transmission, prevalence, and persistence.Specificity of L1 peptides versus virus-like particles for detection of human papillomavirus-positive cervical lesions in females attending Engativa Hospital, Bogota, ColombiaStructural differences among cost-effectiveness models of human papillomavirus vaccines.Cervical HPV Infection in Female Sex Workers: A Global Perspective.Prevalence and determinants of high-risk human papillomavirus infection in male genital warts.The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps.The cost effectiveness of human papillomavirus vaccines: a systematic review.Expanded strain coverage for a highly successful public health tool: prophylactic 9-valent human papillomavirus vaccine.Risk of cancer in patients with genital warts: A nationwide, population-based cohort study in Taiwan.Epidemiology of human papillomavirus on anogenital warts in Portugal - The HERCOLES study.Impact of HPV vaccination: health gains in the Italian female population.Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV).Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel: accounting for CIN1 and genital warts in addition to CIN2/3 and cervical cancer.
P2860
Q24651563-F4FDA8CE-919E-4064-BD3A-840BBF700721Q26799791-3706B85D-A64A-4258-9814-55FC885E9E71Q33713018-F64B9219-EC1F-4308-B34F-7558166EC7CEQ33718690-EBDC64B3-D8EC-41AC-8C9C-1CB389CE47BAQ33779542-303C1F90-068E-4A99-8CEF-06000B31E484Q33834660-FE58C505-7287-4FAB-B48A-B67063B0D691Q33840853-84617414-2C9B-4243-9D98-BB666E66BF38Q34310582-A434818D-2021-4346-B610-6E845716FD73Q34325506-67DC6384-53F1-45DD-94D7-4C365D196302Q34490403-7FA576BF-7883-4972-A34B-F6724DDAA00AQ34551969-2A1E52EF-F679-436C-9228-E40497E566FCQ34843163-F9E0A868-B9CE-4C1B-B994-0ADF8B0BE153Q35209618-800F5FC0-7C7B-4F81-8A96-A98AE28A10C1Q35484171-9FF5171C-BF8A-4257-8CE8-64AB5AC4964FQ35876855-00335B37-7FC1-43AB-8DB6-2A087DE085F6Q36007989-E8543CE6-E4FF-4FBF-8DC3-74D88B750736Q36134618-051EF240-0AB3-4309-8138-35345227B205Q36740006-AA9F38C0-6BFD-40BB-931D-CAD2CDD548EDQ36784430-8C1F1A4D-C611-49EC-9902-C2BC877AC6A3Q36957928-87429253-8D5E-4D0E-B1FA-4636287FAF24Q37259581-72B2106D-DA00-4F27-8AD6-8FB0D3BAB293Q37559727-20E4F04B-1E6E-47B9-B374-54216DF654E2Q37642113-2903E9E8-0779-473A-8100-73503C5A2A65Q37912062-370C7BD9-FA56-4B59-82A8-9680413C6235Q37993109-1B885939-D6B9-4FB5-B859-824401C5A7B1Q38682763-C6F02E43-7DD8-4D35-BD78-ABE3CC7A23C3Q40094492-E4C7B956-EA71-4374-9766-FF62A9015808Q40209242-7E311458-8B09-4949-8E1B-E8EC5FEAB613Q42368107-348E9799-916C-4664-BCB6-EC1F860466B3Q43462309-22505F20-81B9-4F25-9275-D7799FA8ADB6Q46018724-BDDD7D82-74A1-4700-9FDD-6DCCA0012125Q51175133-6E5C3C87-2C49-4D21-9D05-8B86E4AEA4DB
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Human papillomavirus: the burden of infection.
@ast
Human papillomavirus: the burden of infection.
@en
type
label
Human papillomavirus: the burden of infection.
@ast
Human papillomavirus: the burden of infection.
@en
prefLabel
Human papillomavirus: the burden of infection.
@ast
Human papillomavirus: the burden of infection.
@en
P1476
Human papillomavirus: the burden of infection.
@en
P2093
Emmanuel Masongsong
P356
10.1097/01.OGX.0000221010.82943.8C
P433
P577
2006-06-01T00:00:00Z